Trademark: 87891442
Word
A ANIVIVE
Status
Registered
Status Code
700
Status Date
Tuesday, September 26, 2023
Serial Number
87891442
Registration Number
7176344
Registration Date
Tuesday, September 26, 2023
Mark Type
3000
Filing Date
Tuesday, April 24, 2018
Published for Opposition
Tuesday, May 19, 2020

Trademark Owner History
Anivive Lifesciences, Inc - Original Registrant

Classifications
5 Nutraceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders; Pharmaceuticals, namely, pharmaceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders; Vaccines in the field of veterinary medicine; Therapeutic pharmaceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders
42 Drug discovery services for veterinary medicine; providing pharmaceutical and medical research services and clinical, medical and scientific research information in the field of animal health; analysis services for veterinary medicine, namely, clinical, medical and scientific research; obtaining, recording, analyzing, reporting and modeling data for animal health purposes, namely, electronic monitoring and reporting of clinical information, namely, age, sex, breed, neuter status, body weight, body condition score, blood pressure, heart rate, frequency and character of respiration, appetite, presence or absence of vomiting, activity level, food and water intake, frequency and character of urination and defecation, of animals, using computers or sensors; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for use in database management, for use as a spreadsheet, for word processing, for statistical analysis, data aggregation, data processing, report generation, data sharing, remote data management, remote project management, and data analysis in the field of veterinary medicine for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for assisting in drug discovery in the nature of managing clinical trials for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software to facilitate ordering and delivery of medications and treatment to animal owners, distributors and veterinary health care providers for animal health purposes
The mark consists of dotted "A" with the word "ANIVIVE".
Color is not claimed as a feature of the mark.

Trademark Events
Sep 26, 2023
Notice Of Registration Confirmation Emailed
Sep 26, 2023
Registered-Principal Register
Aug 23, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 22, 2023
Allowed Principal Register - Sou Accepted
Jul 31, 2023
Statement Of Use Processing Complete
Jul 14, 2023
Use Amendment Filed
Jul 14, 2023
Teas Statement Of Use Received
Mar 1, 2023
Assigned To Examiner
Feb 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2023
Sou Extension 5 Granted
Jan 11, 2023
Sou Extension 5 Filed
Jan 26, 2023
Case Assigned To Intent To Use Paralegal
Jan 11, 2023
Sou Teas Extension Received
Jun 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 17, 2022
Sou Extension 4 Granted
Jun 17, 2022
Sou Extension 4 Filed
Jun 17, 2022
Sou Teas Extension Received
Jan 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2022
Sou Extension 3 Granted
Jan 7, 2022
Sou Extension 3 Filed
Jan 7, 2022
Sou Teas Extension Received
Jul 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 1, 2021
Sou Extension 2 Granted
Jul 1, 2021
Sou Extension 2 Filed
Jul 1, 2021
Sou Teas Extension Received
Jan 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2021
Sou Extension 1 Granted
Jan 7, 2021
Sou Extension 1 Filed
Jan 7, 2021
Sou Teas Extension Received
Jul 14, 2020
Noa E-Mailed - Sou Required From Applicant
May 19, 2020
Official Gazette Publication Confirmation E-Mailed
May 19, 2020
Published For Opposition
Apr 29, 2020
Notification Of Notice Of Publication E-Mailed
Apr 13, 2020
Exparte Appeal Terminated
Apr 13, 2020
Approved For Pub - Principal Register
Apr 13, 2020
Examiner's Amendment Entered
Apr 13, 2020
Notification Of Examiners Amendment E-Mailed
Apr 13, 2020
Examiners Amendment E-Mailed
Apr 13, 2020
Examiners Amendment -Written
Mar 31, 2020
Teas/Email Correspondence Entered
Mar 31, 2020
Correspondence Received In Law Office
Mar 31, 2020
Assigned To Lie
Mar 23, 2020
Teas Request For Reconsideration Received
Mar 23, 2020
Ex Parte Appeal-Instituted
Mar 23, 2020
Jurisdiction Restored To Examining Attorney
Mar 23, 2020
Exparte Appeal Received At Ttab
Sep 25, 2019
Notification Of Final Refusal Emailed
Sep 25, 2019
Final Refusal E-Mailed
Sep 25, 2019
Final Refusal Written
Aug 27, 2019
Teas/Email Correspondence Entered
Aug 26, 2019
Correspondence Received In Law Office
Aug 26, 2019
Teas Response To Office Action Received
Mar 4, 2019
Notification Of Non-Final Action E-Mailed
Mar 4, 2019
Non-Final Action E-Mailed
Mar 4, 2019
Non-Final Action Written
Feb 11, 2019
Teas/Email Correspondence Entered
Feb 11, 2019
Correspondence Received In Law Office
Feb 11, 2019
Teas Response To Office Action Received
Aug 16, 2018
Notification Of Priority Action E-Mailed
Aug 16, 2018
Priority Action E-Mailed
Aug 16, 2018
Priority Action Written
Aug 14, 2018
Assigned To Examiner
May 4, 2018
Notice Of Design Search Code E-Mailed
May 3, 2018
New Application Office Supplied Data Entered
Apr 27, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24